Oral Palonosetron 0.5 mg	Oral Palonosetron 0.75 mg	Complete response (no emesis + no rescue medication)	-1	-1	The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0–24 h) and delayed (24–120 h) phase
IV Palonosetron 0.5 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	1134	1452	Acute CR rates were 73.5, 76.3, 74.1, and 70.4 % for all patients receiving the palonosetron 0.25, 0.50, and 0.75 mg oral doses, and for IV palonosetron 0.25 mg, respectively; delayed CR (24–120 h) rates were 59.4, 62.5, 60.1, and 65.4 %, and overall CR (0–120 h) rates were 53.5, 58.8, 53.2, and 59.3 %, respectively.
Oral Palonosetron 0.75 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	-1	-1	Similarly, no statistically significant difference was seen in the comparisons between 0.25 mg oral and 0.25 mg IV palonosetron in the acute, delayed, and overall phases [respectively, 59.4 vs 57.4 % (p = 0.725), 41.9 vs 47.5 % (p = 0.316), 38.1 vs 42.6 % (p = 0.411)] and between 0.75 mg oral vs 0.25 mg IV palonosetron in the acute [62.7 vs 57.4 % (p = 0.337)], delayed [46.2 vs 47.5 % (p = 0.811)], and overall phases [41.8 vs 42.6 % (p = 0.681)]
Oral Palonosetron 0.75 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	-1	-1	The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0–24 h) and delayed (24–120 h) phase
IV Palonosetron 0.5 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	11633	11831	non-inferiority was achieved for the 0.25 mg (lower bound of 98.3 % CI was −8.9 %) oral doses and 0.75 mg (lower bound of 98.3 % CI was −8.9 %) for oral doses compared to the 0.25 mg IV formulation.
Oral Palonosetron 0.5 mg	Oral Palonosetron 0.75 mg	Complete response (no emesis + no rescue medication)	-1	-1	<td rowspan="3">0–24&nbsp;h</td><td colspan="2">Total</td><td align="char" char="[">73.5 [65.8, 80.2]</td><td align="char" char="[">76.3 [68.8, 82.5]</td><td align="char" char="[">74.1 [66.4, 80.5]</td><td align="char" char="[">70.4 [62.7, 77.1]</td>
Oral Palonosetron 0.5 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	-1	-1	The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0–24 h) and delayed (24–120 h) phases, as well as the overall 0–120 h time interval (Fig. 2).
Oral Palonosetron 0.75 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	-1	-1	The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0–24 h) and delayed (24–120 h) phases, as well as the overall 0–120 h time interval
Oral Palonosetron 0.5 mg	Oral Palonosetron 0.25 mg	Complete response (no emesis + no rescue medication)	-1	-1	The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0–24 h) and delayed (24–120 h) phase
